Historical Stock Price
CLBS historical stock prices picture
CLBS (CLBS) has the following price history information. Looking back at CLBS historical stock prices for the last five trading days, on September 08, 2022, CLBS opened at $0.50, traded as high as $0.52 and as low as $0.50, and closed at $0.50. Trading volume was a total of 233.50K shares. On September 09, 2022, CLBS opened at $0.50, traded as high as $0.53 and as low as $0.50, and closed at $0.51. Trading volume was a total of 98.10K shares. On September 12, 2022, CLBS opened at $0.52, traded as high as $0.52 and as low as $0.51, and closed at $0.51. Trading volume was a total of 96.10K shares. On September 13, 2022, CLBS opened at $0.50, traded as high as $0.52 and as low as $0.50, and closed at $0.51. Trading volume was a total of 34.80K shares. On September 14, 2022, CLBS opened at $0.65, traded as high as $0.65 and as low as $0.38, and closed at $0.43. Trading volume was a total of 26.77M shares.

CLBS Historical Stock Prices By Date:

CLBS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLBS shares, starting with a $10,000 purchase of CLBS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 09/14/2022
Start price/share: $70.50
End price/share: $0.43
Dividends collected/share: $0.00
Total return: -99.39%
Average Annual Total Return: -45.26%
Starting investment: $10,000.00
Ending investment: $60.99
Years: 8.46
Date Open High Low Close Volume
09/08/2022 $0.50 $0.52 $0.50 $0.50 233.50K
09/09/2022 $0.50 $0.53 $0.50 $0.51 98.10K
09/12/2022 $0.52 $0.52 $0.51 $0.51 96.10K
09/13/2022 $0.50 $0.52 $0.50 $0.51 34.80K
09/14/2022 $0.65 $0.65 $0.38 $0.43 26.77M
Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the development of treatments and reversal of severe diseases. Co.'s product candidates include: XOWNA®, which is a Phase 2a study and an ongoing follow-on Phase 2b study in the U.S. for the treatment of coronary microvascular dysfunction; HONEDRA®, which is eligible for early conditional approval in Japan for the treatment of critical limb ischemia based on the results of a clinical trial; and CLBS201, which is designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney disease related to type 2 diabetes.
Date Close
09/08/2022$0.50
09/09/2022$0.51
09/12/2022$0.51
09/13/2022$0.51
09/14/2022$0.43
CLBS is categorized under the Healthcare sector; below are some other companies in the same sector:

CLCD Historical Stock Prices
CLDN Historical Stock Prices
CLDX Historical Stock Prices
CLRB Historical Stock Prices
CLRBW Historical Stock Prices
CLSD Historical Stock Prices
CLSN Historical Stock Prices
CLVS Historical Stock Prices
CMD Historical Stock Prices
CMN Historical Stock Prices

Also explore: CLBS shares outstanding history

Email EnvelopeFree CLBS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CLBS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.